methamphetamine has been researched along with bupropion in 51 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (3.92) | 18.7374 |
| 1990's | 1 (1.96) | 18.2507 |
| 2000's | 17 (33.33) | 29.6817 |
| 2010's | 24 (47.06) | 24.3611 |
| 2020's | 7 (13.73) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Buckett, WR; Frankland, AT; Gosden, J; Heal, DJ; Hutchins, LJ; Luscombe, GP; Prow, MR | 1 |
| Hudson, JI; Pope, HG | 1 |
| Joshi, MA; Manekar, MS; Muley, MP | 1 |
| Gomita, Y; Nakagawa, T; Ohyama, T; Okamura, H; Ukai, K | 1 |
| Bardo, MT; Dwoskin, LP; Neugebauer, N; Rauhut, AS | 1 |
| Kim, M; Myung, SW; Yoon, SH | 1 |
| Berigan, T | 1 |
| Birdsall, E; Carroll, FI; Fleckenstein, AE; Gibb, JW; Hanson, GR; Hanson, JE; Johnson-Davis, KL; Rau, KS; Wilkins, DG | 1 |
| Chiang, N; De La Garza, R; Elkashef, A; Fong, T; Kahn, R; Li, SH; Newton, TF; Roache, JD; Wallace, CL | 2 |
| Ling, W; Rawson, R; Shoptaw, S | 1 |
| Anderson, AL; Campbell, J; Carlton, B; Chiang, N; Elkashef, AM; Gorodetzky, C; Haning, W; Holmes, T; Kahn, R; Li, SH; Ling, W; Mawhinney, J; McCann, M; Pearce, VJ; Rawson, RA; Smith, EV; Vocci, F; Weis, D | 1 |
| Bevins, RA; Reichel, CM; Wilkinson, JL | 1 |
| Bevins, RA; Linkugel, JD; Reichel, CM | 1 |
| De La Garza, R; Heinzerling, KG; Ling, W; Newton, T; Rotheram-Fuller, E; Shoptaw, S; Steward, T; Swanson, AN; Wang, J | 1 |
| Kampman, KM | 1 |
| Bevins, RA; Grant, KM; Murray, JE; Reichel, CM | 1 |
| Elkashef, A; Hanson, G; Tiihonen, J; Vocci, F; White, J; Wickes, W | 1 |
| Bevins, RA; Li, C; Wilkinson, JL | 1 |
| Dean, AC; Heinzerling, KG; Kalechstein, AD; Kitchen, CM; London, ED; Shoptaw, S; Sugar, CA; Swanson, AN | 1 |
| Chu, P; Colfax, GN; Das, M; Matheson, T; Santos, D; Santos, GM; Shoptaw, S; Vittinghoff, E | 1 |
| Gilman, JP; Goldberg, SR; McCann, DJ; Panlilio, LV; Schindler, CW | 1 |
| Li, SH; McCann, DJ | 1 |
| Brensilver, M; Furst, BA; Heinzerling, KG; Shoptaw, SJ; Swanson, AN; Telesca, D | 1 |
| Rappaport, BA; Roca, R; Rosebraugh, CJ; Winchell, C | 1 |
| Brensilver, M; Heinzerling, KG; Shoptaw, SJ; Swanson, AN | 1 |
| Gadzhyan, J; Heinzerling, KG; McCracken, J; Rodriguez, F; Shoptaw, S; van Oudheusden, H | 1 |
| Liechti, ME; Simmler, LD; Wandeler, R | 1 |
| Hokazono, M; Mori, T; Ogawa, Y; Rahmadi, M; Shibasaki, M; Suzuki, T; Wang, TC | 1 |
| Bevan, M; Davidson, C; Meintel, M; Opacka-Juffry, J; Patel, N; Pinnell, T | 1 |
| Hall, TM; Heinzerling, KG; Shoptaw, SJ; Swanson, AN; Wu, Y; Yi, Y | 1 |
| Coffin, P; Colfax, G; Hermanstyne, KA; Santos, D; Santos, GM; Vittinghoff, E | 1 |
| Carson, DS; Taylor, ER | 1 |
| Glaser, PE; Hays, LR; Pike, E; Rush, CR; Stoops, WW | 1 |
| Banks, ML; Blough, BE | 1 |
| Anderson, AL; Campbell, J; Chiang, N; Dickerson, DL; Elkashef, AM; Galloway, GP; Haning, W; Holmes, TH; Kahn, R; Li, SH; Markova, D; Roache, JD; Stock, C | 1 |
| Banks, ML; Blough, BE; Smith, DA | 1 |
| Krähenbühl, S; Liechti, ME; Luethi, D | 1 |
| Bevins, RA; Charntikov, S; Pittenger, ST; Pudiak, CM | 1 |
| Abdulla Jallb, AH; Amira Roslan, NF; Pandy, V; Sajat, A; Vijeepallam, K; Wai, YC | 1 |
| Ahmadi, J; Biuseh, M; Sahraian, A | 1 |
| Bart, G; Carmody, T; Coffin, P; Dela Cruz, A; Ghitza, UE; Kim, M; Ling, W; Nunes, EV; Rush, AJ; Schmitz, J; Sharma, G; Shoptaw, S; Shores-Wilson, K; Sonne, SC; Sparenborg, S; Trivedi, MH; Wahle, A; Wakhlu, S; Walker, R; Wiest, K | 1 |
| Ciccarone, D; Shoptaw, S | 1 |
| Cheaha, D; Kumarnsit, E; Niyomdecha, S; Nukitram, J; Thawaii, S | 1 |
| Cheaha, D; Kumarnsit, E; Nukitram, J | 1 |
| Carmody, T; Northrup, TF; Schmitz, JM; Shoptaw, S; Stotts, AL; Trivedi, MH; Villarreal, YR; Weaver, MF; Yammine, L; Yoon, JH | 1 |
| Carmody, T; Cook, RR; Korthuis, PT; Levander, XA; Potter, JS; Shoptaw, S; Trivedi, MH | 1 |
| Carmody, TJ; Coffin, PO; Kidd, JD; Levin, FR; Nunes, EV; Shoptaw, SJ; Smiley, SL; Trivedi, MH | 1 |
5 review(s) available for methamphetamine and bupropion
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Antidepressant drug therapy for bulimia: current status.
Topics: Antidepressive Agents; Bupropion; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Feeding and Eating Disorders; Fenfluramine; Humans; Hyperphagia; Lithium; Lithium Carbonate; Methamphetamine; Monoamine Oxidase Inhibitors; Nomifensine; Phenytoin; Placebos; Propiophenones; Valproic Acid | 1986 |
Management of methamphetamine abuse and dependence.
Topics: Baclofen; Benzhydryl Compounds; Brain; Bupropion; Cognition Disorders; Cognitive Behavioral Therapy; Humans; Methamphetamine; Modafinil; Nerve Net; Substance Withdrawal Syndrome; Substance-Related Disorders | 2006 |
Pharmacotherapy of methamphetamine addiction: an update.
Topics: Antipsychotic Agents; Aripiprazole; Bupropion; Central Nervous System Stimulants; Dextroamphetamine; Drug Therapy; Humans; Lobeline; Methamphetamine; Methylphenidate; Narcotic Antagonists; Nicotinic Agonists; Piperazines; Prevalence; Quinolones; Recurrence; Substance-Related Disorders | 2008 |
Understanding Stimulant Use and Use Disorders in a New Era.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adult; Anticonvulsants; Behavior Therapy; Bupropion; Central Nervous System Stimulants; Cocaine-Related Disorders; Cognitive Dysfunction; Comorbidity; Dopamine Uptake Inhibitors; Female; Humans; Illicit Drugs; Male; Mental Disorders; Methamphetamine; Mirtazapine; Neurobiology; Neurodegenerative Diseases; Opiate Overdose; Substance Withdrawal Syndrome; Topiramate; Transgender Persons; United States | 2022 |
19 trial(s) available for methamphetamine and bupropion
| Article | Year |
|---|---|
Antidepressant drug therapy for bulimia: current status.
Topics: Antidepressive Agents; Bupropion; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Feeding and Eating Disorders; Fenfluramine; Humans; Hyperphagia; Lithium; Lithium Carbonate; Methamphetamine; Monoamine Oxidase Inhibitors; Nomifensine; Phenytoin; Placebos; Propiophenones; Valproic Acid | 1986 |
Safety of intravenous methamphetamine administration during treatment with bupropion.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Blood Pressure; Bupropion; Double-Blind Method; Female; Heart Rate; Humans; Male; Methamphetamine; Middle Aged | 2005 |
Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Antidepressive Agents, Second-Generation; Bupropion; Cues; Demography; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Female; Humans; Male; Methamphetamine; Middle Aged; Pain Measurement; Time Factors | 2006 |
Bupropion for the treatment of methamphetamine dependence.
Topics: Adult; Amphetamine-Related Disorders; Bupropion; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Methamphetamine; Middle Aged; Mississippi; Psychotherapy; Severity of Illness Index; Treatment Outcome | 2008 |
Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Central Nervous System Stimulants; Female; Humans; Male; Methamphetamine; Placebos; Substance Abuse Detection; Substance-Related Disorders; Survival Analysis; Treatment Outcome | 2008 |
Predicting adherence to treatment for methamphetamine dependence from neuropsychological and drug use variables.
Topics: Adult; Affect; Amphetamine-Related Disorders; Analysis of Variance; Antidepressive Agents, Second-Generation; Bupropion; Cognitive Behavioral Therapy; Crime; Female; Humans; Male; Memory, Short-Term; Methamphetamine; Neuropsychological Tests; Patient Compliance; Predictive Value of Tests; Reaction Time; Smoking; Social Environment; Socioeconomic Factors; Treatment Outcome | 2009 |
Feasibility and acceptability of a phase II randomized pharmacologic intervention for methamphetamine dependence in high-risk men who have sex with men.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Antidepressive Agents, Second-Generation; Bupropion; Feasibility Studies; Homosexuality, Male; Humans; Male; Medication Adherence; Methamphetamine; Middle Aged; Patient Selection; Young Adult | 2010 |
A novel, nonbinary evaluation of success and failure reveals bupropion efficacy versus methamphetamine dependence: reanalysis of a multisite trial.
Topics: Adult; Bupropion; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Methamphetamine; Middle Aged; Substance-Related Disorders; Treatment Outcome | 2012 |
Cigarette smoking as a target for potentiating outcomes for methamphetamine abuse treatment.
Topics: Adult; Amphetamine-Related Disorders; Bupropion; Cognitive Behavioral Therapy; Double-Blind Method; Female; Humans; Male; Methamphetamine; Smoking; Smoking Cessation; Treatment Outcome | 2013 |
A retrospective analysis of two randomized trials of bupropion for methamphetamine dependence: suggested guidelines for treatment discontinuation/augmentation.
Topics: Adult; Amphetamine-Related Disorders; Bupropion; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Guidelines as Topic; Humans; Male; Methamphetamine; Randomized Controlled Trials as Topic; Retrospective Studies; ROC Curve; Substance Abuse Detection; Treatment Outcome | 2012 |
Pilot randomized trial of bupropion for adolescent methamphetamine abuse/dependence.
Topics: Adolescent; Ambulatory Care; Amphetamine-Related Disorders; Antidepressive Agents, Second-Generation; Bupropion; Delayed-Action Preparations; Female; Humans; Los Angeles; Male; Methamphetamine; Pilot Projects; Secondary Prevention; Sex Factors; Substance Abuse Detection; Substance Abuse, Intravenous; Young Adult | 2013 |
Randomized, placebo-controlled trial of bupropion in methamphetamine-dependent participants with less than daily methamphetamine use.
Topics: Adult; Amphetamine-Related Disorders; Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Male; Medication Adherence; Methamphetamine; Middle Aged; Treatment Outcome | 2014 |
Event-level relationship between methamphetamine use significantly associated with non-adherence to pharmacologic trial medications in event-level analyses.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Bupropion; Female; Humans; Logistic Models; Male; Medication Adherence; Methamphetamine; Mianserin; Middle Aged; Mirtazapine; Motivation; Substance Abuse Detection; Young Adult | 2014 |
Bupropion for the treatment of methamphetamine dependence in non-daily users: a randomized, double-blind, placebo-controlled trial.
Topics: Adult; Amphetamine-Related Disorders; Bupropion; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Humans; Male; Medication Adherence; Methamphetamine; Psychotherapy, Group; Treatment Outcome | 2015 |
A randomized clinical trial on the effects of bupropion and buprenorphine on the reduction of methamphetamine craving.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Analgesics, Opioid; Behavior, Addictive; Buprenorphine; Bupropion; Central Nervous System Stimulants; Craving; Dopamine Uptake Inhibitors; Double-Blind Method; Humans; Iran; Male; Methamphetamine; Middle Aged; Substance Withdrawal Syndrome; Time Factors; Treatment Outcome; Young Adult | 2019 |
Bupropion and Naltrexone in Methamphetamine Use Disorder.
Topics: Administration, Oral; Adolescent; Adult; Aged; Amphetamine-Related Disorders; Bupropion; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Injections; Male; Medication Adherence; Methamphetamine; Middle Aged; Naltrexone; Narcotic Antagonists; Young Adult | 2021 |
Naltrexone plus bupropion reduces cigarette smoking in individuals with methamphetamine use disorder: A secondary analysis from the CTN ADAPT-2 trial.
Topics: Bupropion; Cigarette Smoking; Humans; Methamphetamine; Naltrexone; Narcotic Antagonists; Prospective Studies | 2023 |
A gender-based secondary analysis of the ADAPT-2 combination naltrexone and bupropion treatment for methamphetamine use disorder trial.
Topics: Adult; Bupropion; Central Nervous System Stimulants; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Methamphetamine; Naltrexone; Pregnancy | 2023 |
Sexual orientation differences among men in a randomized clinical trial of extended-release naltrexone and bupropion for methamphetamine use disorder.
Topics: Bupropion; Double-Blind Method; Female; Homosexuality, Male; Humans; Male; Methamphetamine; Naltrexone; Prospective Studies; Sexual and Gender Minorities; Sexual Behavior | 2023 |
28 other study(ies) available for methamphetamine and bupropion
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
A comparison of the effects of sibutramine hydrochloride, bupropion and methamphetamine on dopaminergic function: evidence that dopamine is not a pharmacological target for sibutramine.
Topics: Animals; Antidepressive Agents; Blepharoptosis; Brain Chemistry; Bupropion; Chromatography, High Pressure Liquid; Conditioning, Operant; Corpus Striatum; Cyclobutanes; Dopamine; Generalization, Psychological; Male; Methamphetamine; Rats; Reserpine; Stereotyped Behavior; Substantia Nigra | 1992 |
Effect of bupropion on dopamine and 5-hydroxytryptamine-mediated behaviour in mice.
Topics: 5-Hydroxytryptophan; Animals; Antidepressive Agents; Behavior, Animal; Bupropion; Clomipramine; Dopamine; Drug Interactions; Humans; Male; Methamphetamine; Mice; Motor Activity; Pargyline; Propiophenones; Serotonin; Stereotyped Behavior | 1984 |
Effect of dopaminergic drugs on the reserpine-induced lowering of hippocampal theta wave frequency in rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antipsychotic Agents; Atropine; Bupropion; Cyclobutanes; Desipramine; Dopamine Agents; Dopamine Agonists; Hippocampus; Male; Methamphetamine; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine; Reserpine; Theta Rhythm | 2000 |
Effect of bupropion on nicotine self-administration in rats.
Topics: Animals; Antidepressive Agents; Apomorphine; Bupropion; Central Nervous System Stimulants; Dopamine Agonists; Dose-Response Relationship, Drug; Male; Methamphetamine; Nicotine; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Self Administration; Sucrose | 2003 |
Analysis of benzene ethylamine derivatives in urine using the programmable dynamic liquid-phase microextraction (LPME) device.
Topics: Benzene Derivatives; Bupropion; Electronic Data Processing; Ephedrine; Ethylamines; Humans; Mephentermine; Methamphetamine; Microchemistry; Reproducibility of Results; Selegiline; Sensitivity and Specificity; Substance Abuse Detection | 2003 |
Amphetamine-like stimulant cessation in an abusing patient treated with buproprion (Tardiev et al. 2004).
Topics: Bupropion; Dopamine Uptake Inhibitors; Humans; Methamphetamine; Substance-Related Disorders | 2004 |
Bupropion increases striatal vesicular monoamine transport.
Topics: Analysis of Variance; Animals; Biological Transport; Blotting, Western; Bupropion; Corpus Striatum; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Gene Expression Regulation; Male; Methamphetamine; Rats; Rats, Sprague-Dawley; Subcellular Fractions; Synaptic Vesicles; Time Factors; Tissue Distribution; Tritium; Vesicular Monoamine Transport Proteins | 2005 |
Methamphetamine functions as a positive and negative drug feature in a Pavlovian appetitive discrimination task.
Topics: Animals; Bupropion; Cocaine; Conditioning, Classical; Discrimination Learning; Male; Methamphetamine; Naloxone; Rats; Rats, Sprague-Dawley | 2007 |
Bupropion differentially impacts acquisition of methamphetamine self-administration and sucrose-maintained behavior.
Topics: Amphetamine-Related Disorders; Animals; Bupropion; Male; Methamphetamine; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Self Administration; Sucrose | 2008 |
The search for medications to treat stimulant dependence.
Topics: Amphetamine-Related Disorders; Benzhydryl Compounds; Brain; Bupropion; Cocaine; Cocaine-Related Disorders; Combined Modality Therapy; Drug Approval; Humans; Methamphetamine; Modafinil; Propranolol; Psychotropic Drugs; Secondary Prevention; Substance Withdrawal Syndrome; Token Economy | 2008 |
Bupropion attenuates methamphetamine self-administration in adult male rats.
Topics: Amphetamine-Related Disorders; Animals; Behavior, Addictive; Bupropion; Dose-Response Relationship, Drug; Male; Methamphetamine; Rats; Rats, Sprague-Dawley; Self Administration | 2009 |
Pavlovian drug discrimination with bupropion as a feature positive occasion setter: substitution by methamphetamine and nicotine, but not cocaine.
Topics: Bupropion; Cocaine; Conditioning, Classical; Discrimination Learning; Dopamine Uptake Inhibitors; Humans; Methamphetamine; Nicotine; Peritoneum | 2009 |
Comparison of the effects of methamphetamine, bupropion, and methylphenidate on the self-administration of methamphetamine by rhesus monkeys.
Topics: Animals; Bupropion; Central Nervous System Stimulants; Conditioning, Operant; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Feeding Behavior; Macaca mulatta; Male; Methamphetamine; Methylphenidate; Motivation; Self Administration; Substance-Related Disorders | 2011 |
Reanalysis of methamphetamine dependence treatment trial.
Topics: Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Male; Methamphetamine; Substance-Related Disorders; Treatment Outcome | 2012 |
Bupropion, methylphenidate, and 3,4-methylenedioxypyrovalerone antagonize methamphetamine-induced efflux of dopamine according to their potencies as dopamine uptake inhibitors: implications for the treatment of methamphetamine dependence.
Topics: Amphetamine-Related Disorders; Benzodioxoles; Biological Transport; Bupropion; Dopamine; Humans; Methamphetamine; Methylphenidate; Pyrrolidines; Synthetic Cathinone | 2013 |
Comparison of the behavioral effects of bupropion and psychostimulants.
Topics: Animals; Behavior, Animal; Bupropion; Cocaine; Male; Methamphetamine; Mice; Motor Activity; Psychotropic Drugs; Reward; Substance-Related Disorders | 2013 |
Stimulant mechanisms of cathinones - effects of mephedrone and other cathinones on basal and electrically evoked dopamine efflux in rat accumbens brain slices.
Topics: Amphetamine; Amphetamines; Animals; Bupropion; Central Nervous System Stimulants; Cocaine; Diethylpropion; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Electric Stimulation; Iodine Radioisotopes; Male; Methamphetamine; Microelectrodes; Nucleus Accumbens; Propiophenones; Radioligand Assay; Rats, Wistar; Tissue Culture Techniques | 2014 |
Commentary on Heinzerling et al. (2014): a growing methamphetamine dependence therapeutics graveyard.
Topics: Amphetamine-Related Disorders; Bupropion; Humans; Methamphetamine | 2014 |
Naltrexone and bupropion, alone or combined, do not alter the reinforcing effects of intranasal methamphetamine.
Topics: Administration, Intranasal; Adult; Bupropion; Humans; Methamphetamine; Naltrexone; Narcotic Antagonists; Surveys and Questionnaires | 2015 |
Effects of Environmental Manipulations and Treatment with Bupropion and Risperidone on Choice between Methamphetamine and Food in Rhesus Monkeys.
Topics: Animals; Bupropion; Choice Behavior; Conditioning, Operant; Dopamine Agents; Environment; Food; Macaca mulatta; Male; Methamphetamine; Risperidone; Self Administration | 2015 |
Methamphetamine-like discriminative stimulus effects of bupropion and its two hydroxy metabolites in male rhesus monkeys.
Topics: Animals; Antidepressive Agents, Second-Generation; Bupropion; Central Nervous System Stimulants; Conditioning, Operant; Discrimination Learning; Dopamine Antagonists; Dose-Response Relationship, Drug; Macaca mulatta; Male; Methamphetamine; Nicotine; Nicotinic Agonists; Reinforcement, Psychology; Risperidone; Time Factors; Varenicline | 2016 |
Mechanisms of hepatocellular toxicity associated with new psychoactive synthetic cathinones.
Topics: Adenosine Triphosphate; Alkaloids; Benzodioxoles; Bupropion; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Electron Transport Chain Complex Proteins; Hep G2 Cells; Hepatocytes; Humans; Lactic Acid; Membrane Potential, Mitochondrial; Methamphetamine; Mitochondria, Liver; Oxidative Phosphorylation; Oxidative Stress; Oxygen Consumption; Pentanones; Psychotropic Drugs; Pyrrolidines; Reactive Oxygen Species; Synthetic Cathinone | 2017 |
The effect of N-acetylcysteine or bupropion on methamphetamine self-administration and methamphetamine-triggered reinstatement of female rats.
Topics: Acetylcysteine; Amphetamine-Related Disorders; Animals; Bupropion; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Drug-Seeking Behavior; Estrous Cycle; Female; Methamphetamine; Motor Activity; Psychotropic Drugs; Rats, Sprague-Dawley; Self Administration | 2018 |
Methanolic extract of Morinda citrifolia Linn. unripe fruit attenuates methamphetamine-induced conditioned place preferences in mice.
Topics: Animals; Bupropion; Conditioning, Psychological; Extinction, Psychological; Fruit; Male; Methamphetamine; Methanol; Mice, Inbred ICR; Morinda; Motor Activity; Plant Extracts | 2018 |
Neural signaling of methamphetamine craving and seeking intensified by bupropion in the ventral tegmental area-cortico-accumbens circuitry in mice.
Topics: Animals; Bupropion; Craving; Male; Methamphetamine; Mice; Nicotinic Antagonists; Nucleus Accumbens; Ventral Tegmental Area | 2022 |
A 1:1 ratio of cannabidiol: tetrahydrocannabinol attenuates methamphetamine conditioned place preference in mice: A prospective study of antidopaminergic mechanism.
Topics: Animals; Bupropion; Cannabidiol; Central Nervous System Stimulants; Dronabinol; Male; Methamphetamine; Mice; Mice, Inbred ICR; Nucleus Accumbens; Prospective Studies | 2023 |